http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-802258-L

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D319-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D267-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C205-44
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D267-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C205-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-04
filingDate 1980-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1981-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IE-802258-L
titleOfInvention Quinazolines
abstract 2,4-Diaminoquinazolines of the formula <IMAGE> (I) wherein Y1 is hydrogen or chloro, Y2 is OR, Y3 is hydrogen or OR such that when Y1 is hydrogen, Y3 is OR and when Y1 is chloro, Y3 is hydrogen or OR, and the pharmaceutically acceptable salts thereof; R represents an alkyl group having from one to three carbon atoms; taken separately, R1 and R2 are each hydrogen, alkyl having from one to five carbon atoms, cycloalkyl having from three to eight carbon atoms, alkenyl or alkynyl each having from three to five carbon atoms or hydroxy substituted alkyl having from two to five carbon atoms, when taken together with the nitrogen atom to which they are attached R1 and R2 form a substituted or unsubstituted heterocyclic group optionally containing an atom of oxygen, sulfur or a second atom of nitrogen as a ring member; their use as antihypertensive agents, pharmaceutical compositions containing them and intermediates for their production.n[US4287341A]
priorityDate 1979-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424389746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457192620
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID402
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559526
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID947
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65087
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783

Total number of triples: 47.